- Display 15 Products per page
Published: October 1, 2005 | Price: $3,500.00 – $7,000.00
Cancer, with its high prevalence and mortality rate, continues to rank among the world's deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are making continued progress in understanding the disease. Further, cancer drug research is moving from traditional cytotoxic chemotherapies toward higher specificity immunological and biological approaches that...Published: September 4, 2014 | Price: $4,200.00 – $8,400.00
Proteomics Markets for Clinical IVD Applications and Research Applications Kalorama Information report Proteomics Markets for Research and IVD Applications contains market estimates, forecasts and competitive analysis of this important area. Proteomics is the science of proteins, including the study of the function and form proteins. This includes the study of how and why proteins are expressed and how they interact with each other. Proteomics is a large field that has focused on research markets but has applications in therapeutics and...Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...Published: June 29, 2022 | Price: $5,000.00 – $10,000.00
This new report from Kalorama Information is designed to provide an overview of the IVD market in India and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments: Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis,...Published: March 24, 2022 | Price: $5,000.00 – $10,000.00
The Market and Future Potential for Molecular Point of Care (POC), 2022 provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while...Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...Published: May 8, 2019 | Price: $3,000.00 – $6,000.00
Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market...Published: June 1, 2005 | Price: $995.00 – $1,990.00
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...Published: February 19, 2017 | Price: $796.00 – $1,592.00
World Sleep Apnea Device Markets is Kalorama Information's authoritative study on this high-growth market. As part of its coverage, the report provides the following data: Worldwide Respiratory Sleep Apnea APAP Market, 2014-2021 ($millions) Sleep Apnea Bi-Level Market Worldwide Respiratory Sleep Apnea Bi-Level Market, 2014-2021 ($millions Sleep Apnea Facial Interface and Diagnostic Device Market Worldwide Respiratory Sleep Apnea Facial Interface and Diagnostic Device Market, 2014-2021 ($millions) Prevalence of Sleep Apnea, 2015 Sleep Apnea Prevalence by Region and Country, 2015 Worldwide...Published: March 1, 2012 | Price: $3,500.00 – $7,590.00
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality....Published: October 8, 2024 | Price: $6,300.00 – $12,600.00
Act Now – Be Prepared for Tomorrow’s IVD Market Don’t miss your chance to leverage Kalorama Information’s expert insights. Equip your business with the knowledge to anticipate changes, optimize product development, and maximize your strategies in the dynamic IVD landscape. Ready to take action? Purchase the IVD Test Procedure Volumes, 2024-2029 report today and secure your competitive advantage in this billion-dollar industry. Abstract Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends...Published: October 26, 2012 | Price: $3,995.00 – $7,990.00
The coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and has a longer life expectancy, the prevalence of coronary heart disease and co-morbid conditions such as hypertension, diabetes and obesity is projected to rise and stimulate the demand for coronary stents. Additionally, a growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing...Published: February 1, 2011 | Price: $150.00 – $300.00
What are virtual reality technologies and how are they being used in healthcare today? What areas of healthcare are seeing the most use of these products? What is the expected market opportunity for companies entering the market for VR equipment? Who are the main players in the VR market and what moves are they making to grow market share? These are among the questions answered in Kalorama Information's Virtual Reality in Healthcare in the U.S. The use of virtual reality...Published: April 1, 2010 | Price: $3,995.00 – $7,990.00
This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies in Anesthesia The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors. The report includes statistical...Published: March 22, 2017 | Price: $3,196.00 – $6,392.00
The World Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement) The World Market for Respiratory Devices provides revenue data for the global and geographic opportunities for respiratory equipment. The report offers information on the entire respiratory equipment market, product estimates by segment, and market revenues by geographical region for 2016-2021, including global respiratory opportunity percentage by type, 2016 and 2021; opportunity size and growth for 2016-2021; opportunity size and growth for...